XML 31 R16.htm IDEA: XBRL DOCUMENT
v3.26.1

Redeemable Noncontrolling Interests and Noncontrolling Interests | 12 Months Ended
--- | ---
Mar. 31, 2026
Noncontrolling Interest [Abstract] |
Redeemable Noncontrolling Interests and Noncontrolling Interests | Redeemable Noncontrolling Interests and Noncontrolling Interests Redeemable Noncontrolling Interests Noncontrolling interests with redemption features, such as put rights, that are not solely within the Company’s control are considered redeemable noncontrolling interests. During the year ended March 31, 2026, the Company initially recognized redeemable noncontrolling interests of $25 million related to its acquisition of PRISM Vision and $700 million related to its acquisition of Core Ventures. The Company utilized a Monte Carlo simulation model for its periodic valuation of the redeemable noncontrolling interests for both acquisitions. As a result, the Company recorded a fair value adjustment of $87 million, which was recorded as a decrease in the Company’s additional paid-in capital, for the year ended March 31, 2026. The Company also recognized a redemption value adjustment to the Core Ventures redeemable noncontrolling interest of $122 million, which was recorded to “Net income attributable to noncontrolling interests” in the Company’s Consolidated Statement of Operations for the year ended March 31, 2026. Redeemable noncontrolling interests are presented outside of stockholders’ deficit in the Company’s Consolidated Balance Sheet. Refer to Financial Note 2, “Business Acquisitions and Divestitures,” for additional information on the acquisition activity discussed above. Noncontrolling Interests Noncontrolling interests represent third-party equity interests in the Company’s consolidated entities primarily related to ClarusONE, Vantage, and SCRI Oncology. Noncontrolling interests in the Company’s Consolidated Balance Sheets were $395 million and $380 million at March 31, 2026 and 2025, respectively. For the years ended March 31, 2026, 2025, and 2024, the Company allocated a total of $197 million, $186 million, and $158 million of net income to noncontrolling interests, respectively. Changes in noncontrolling interests for the years ended March 31, 2026, 2025, and 2024 were as follows:
| Fiscal 2026 |  | Fiscal 2025 |  | Fiscal 2024
(In millions) | Noncontrolling Interests |  | Redeemable Noncontrolling Interests |  | Noncontrolling Interests |  | Noncontrolling Interests
Beginning balance | $ | 380 |  |  | $ | — |  |  | $ | 372 |  |  | $ | 367 |
Net income attributable to noncontrolling interests | 197 |  |  | 18 |  |  | 186 |  |  | 158 |
Adjustment to redemption value in net income attributable to noncontrolling interests | — |  |  | 122 |  |  | — |  |  | — |
Payments to noncontrolling interests | (182) |  |  | (7) |  |  | (178) |  |  | (152) |
Acquisition of PRISM Vision at fair value | — |  |  | 25 |  |  | — |  |  | — |
Acquisition of Core Ventures at fair value | — |  |  | 700 |  |  | — |  |  | — |
Adjustment to fair value | — |  |  | 87 |  |  | — |  |  | — |
Other | — |  |  | (2) |  |  | — |  |  | (1) |
Ending balance | $ | 395 |  |  | $ | 943 |  |  | $ | 380 |  |  | $ | 372 |

X
- Definition The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 810 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/810/tableOfContent + Details
Name: | us-gaap_MinorityInterestDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_NoncontrollingInterestAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration